linkedin post 2013-03-16 18:23:47

Uncategorized
WHY WE HAVE PERMITTED WIDESPREAD USE OF ANTIBIOTICS IN LIVESTOCK REARING is an anathema to me. Equally, they have been over-utilized in medicine. Everybody has been aware of the dangers of overexposure to antibiotics, namely the formation of drug resistant strains. Well, we are now facing the consequences of our lax behavior. It is going to be challenging to bridge the unmet need given the time it takes to develop and test a new drug. The FDA may need to develop a fast-track pathway to help solve this challenge. View in LinkedIn
Read More

linkedin post 2013-03-22 18:46:31

Uncategorized
ADVentura Capital is up and running now" "" "We will be organizing monthly BIOBASH drinks and nibbles events, with a speaker at THE GILD INTERNATIONAL in BCN at 5 Permanayer, off Psg De Gracia, it will have a small fee to cover costs only. This is to fill a void we have often heard articulated, and allow people to meet and mix. Dates and times will be posted here. We hope to see you all at these events! View in LinkedIn
Read More

linkedin post 2013-03-20 05:40:28

Uncategorized
COCA-COLA CONTAINED 9 MGS OF COCAINE PER GLASS UNTIL 1903, together with caffeine. Today, it has caffeine and heaps of sugar. Doctors are petitioning the FDA to limit caffeine and calories for children, citing health concerns, and NYC Mayor Bloomberg is trying to stop Supersizing of soft drinks. Is it a wonder we have hyperactive, obese children in the US? " "" " http://lnkd.in/tx_4HK View in LinkedIn
Read More

linkedin post 2013-03-22 18:15:27

Uncategorized
THE EU DRUG AGENCY AND POLICY GROUP DVELOP INITIATIVES TO BOOST ANTIBIOTIC development and research in response to the alarm calls about antibiotic resistant strains. While big Pharma may find the market too small, these markets could still be attractive for SME companies, especially if the government sweetened the pie with longer exclusivity like in the US, or tax credits for research spent. http://lnkd.in/yUzPjw View in LinkedIn
Read More

linkedin post 2013-03-20 05:26:13

Uncategorized
PROFESSOR RUDDLE WAS A GIANT AMONG MEN, pioneering transgenic studies at Yale University, and his death is the passing of an epoch of great leaps forward. He created the first transgenic mice, leading the way to all manner of advances in knowledge and application. Today, knockout mice, lacking specific disease genes, and an indispensable tool in medical research. He left his mark on the planet. http://lnkd.in/X5EGWx View in LinkedIn
Read More

linkedin post 2013-03-22 16:58:35

Uncategorized
DIVIDING THE EQUITY PIE IN A STARTUP has as many contrarian opinions as authors. This read summarizes some of them. At the end of the day, there is no formula, and each decision must be customized to the local situation. Take in these views and make up your own mind. http://lnkd.in/QvWxhn View in LinkedIn
Read More

linkedin post 2013-03-22 11:50:02

Uncategorized
HARVARD AND SONY DEVELOP HUMAN ORGANS ON CHIPS, as a means for relevant drug testing. By using homogeneous patient samples, with specific mutations that respond to a drug, and eventually use this disease subtype in clinical trials to gain greater chance of success.. Rather than starting with animal testing, which is often misleading, this approach is more promising. On a second application, it may help path the way to grow organs fir human transplantation in years to come. http://lnkd.in/6--xGa View in LinkedIn
Read More

linkedin post 2013-03-22 07:10:39

Uncategorized
BIOLOGIC DRUGS WILL GENERATE 160 BN USD IN WORLDWIDE SALES IN 2013, and be 50% of new drug approvals in the US in coming years. Most are monoclonal antibodies. Caesar Milstein of the Cambridge University MRC Unit invented monoclonals. A framed letter on his office wall was the irritated response to his request to the MRC for a patent. It suggested that Dr. Milstein stop pestering them with these foolish requests. Needless to say, this was an historic blunder by this beleaguered licensing officer. View in LinkedIn
Read More